MetLife Investment Management LLC Acquires 10,084 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST)

MetLife Investment Management LLC increased its holdings in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) by 14.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 80,422 shares of the company’s stock after buying an additional 10,084 shares during the period. MetLife Investment Management LLC’s holdings in LifeStance Health Group were worth $563,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the business. CIBC Asset Management Inc acquired a new stake in LifeStance Health Group during the 2nd quarter worth $53,000. Algert Global LLC bought a new position in shares of LifeStance Health Group in the 2nd quarter worth $57,000. Victory Capital Management Inc. grew its stake in shares of LifeStance Health Group by 27.0% during the second quarter. Victory Capital Management Inc. now owns 14,407 shares of the company’s stock worth $71,000 after purchasing an additional 3,063 shares during the period. Park Edge Advisors LLC bought a new stake in LifeStance Health Group in the third quarter valued at about $73,000. Finally, Townsquare Capital LLC acquired a new position in LifeStance Health Group in the third quarter valued at about $73,000. 85.50% of the stock is currently owned by institutional investors and hedge funds.

LifeStance Health Group Trading Up 1.7 %

NASDAQ LFST opened at $7.34 on Friday. LifeStance Health Group, Inc. has a one year low of $4.64 and a one year high of $9.20. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. The firm has a market cap of $2.81 billion, a P/E ratio of -28.23 and a beta of 1.28. The stock’s 50-day moving average is $7.13 and its 200-day moving average is $6.28.

LifeStance Health Group (NASDAQ:LFST) last announced its earnings results on Thursday, November 7th. The company reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.07) by $0.05. LifeStance Health Group had a negative net margin of 7.90% and a negative return on equity of 6.66%. The firm had revenue of $312.70 million for the quarter, compared to the consensus estimate of $302.25 million. During the same period last year, the company posted ($0.17) EPS. The business’s quarterly revenue was up 18.9% on a year-over-year basis. Sell-side analysts anticipate that LifeStance Health Group, Inc. will post -0.2 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Barclays upped their price target on LifeStance Health Group from $6.00 to $7.00 and gave the company an “underweight” rating in a research note on Monday, November 11th. UBS Group lowered their target price on shares of LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating for the company in a research note on Thursday, August 15th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $8.50.

Insider Activity at LifeStance Health Group

In other LifeStance Health Group news, Director Robert Bessler sold 75,000 shares of the stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $7.54, for a total transaction of $565,500.00. Following the completion of the transaction, the director now owns 1,424,447 shares in the company, valued at approximately $10,740,330.38. This represents a 5.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 6.60% of the stock is currently owned by insiders.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.